BridgeBio Pharma, Inc. License Agreements

9 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 2 to License Agreement between Stanford University and Eidos Therapeutics, Inc.
License Agreements
BridgeBio Pharma, Inc.
Biotechnology
2023
Fourth Amendment to Exclusive License Agreement between The Regents of the University of California and TheRas, Inc.
License Agreements
BridgeBio Pharma, Inc.
Biotechnology
2020
License Agreement between Eidos Therapeutics, Inc. and Alexion Pharma International Operations Unlimited Company (September 9, 2019)
License Agreements
BridgeBio Pharma, Inc.
Biotechnology
CA
2019
Cell Line License Agreement between Life Technologies Corporation and BridgeBio Services, Inc. (November 15, 2018)
License Agreements
BridgeBio Pharma, Inc.
Biotechnology
CA
2019
Exclusive Patent License Agreement between Leidos Biomedical Research, Inc. (Frederick National Laboratory for Cancer Research) and Theras, Inc.
License Agreements
BridgeBio Pharma, Inc.
Biotechnology
2019
Collaboration and License Agreement among The University of Texas M.D. Anderson Cancer Center, The Board of Regents of the University of Texas System, and PTP Pharmaceuticals, Inc.
License Agreements
BridgeBio Pharma, Inc.
Biotechnology
TX
2019
Exclusive License Agreement between The Regents of the University of California and TheRas, Inc. for K-Ras 4B Tethering Compounds
License Agreements
BridgeBio Pharma, Inc.
Biotechnology
DE
2019
License Agreement between Novartis International Pharmaceutical Ltd. and QED Therapeutics, Inc. (January 29, 2018)
License Agreements
BridgeBio Pharma, Inc.
Biotechnology
DE
2019
Exclusive Patent License and Equity Agreement between Stanford University and Eidos Therapeutics, Inc.
License Agreements
BridgeBio Pharma, Inc.
Biotechnology
CA
2019